Inogen | INGN - 应收帐款人





应收帐款人 更改 日
Abbott USD 10.57B 171M 2025-12
Accuray USD 91.79M 7.07M 2024-09
AngioDynamics USD 44.43M 1.79M 2025-09
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 66.65M 3.67M 2025-12
Baxter International USD 2.01B 231M 2025-12
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Boston Scientific USD 2.83B 13M 2025-09
Chart Industries USD 1.74B 12.5M 2025-09
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.28B 167.3M 2025-12
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Globus Medical USD 743.66M 55.54M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 516.9M 54.7M 2025-12
Masimo USD 391.9M 36M 2025-12
Medtronic USD 6.36B 30M 2025-12
Orthofix International USD 135.75M 4.94M 2025-12
Philips EUR 3.8B 266M 2025-12
ResMed USD 985.63M 78.36M 2025-12
Steris USD 990.6M 43.3M 2025-12
Stryker USD 4.04B 396M 2025-12
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 345.58M 247.07M 2025-12
X T L Biopharmaceuticals USD 90K 9K 2025-06
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12